Part I | Chapter 7 152 References 1. Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, et al. Stereotactic Body Radiotherapy for Localised Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. Int J Radiat Oncol 2019;104:778– 89. 2. Widmark A, Gunnlaugsson A, Beckman L, Thellenberg-Karlsson C, Hoyer M, Lagerlund M, et al. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, noninferiority, phase 3 trial. Lancet 2019;394:385–95. 3. Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, et al. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol 2019;20:1531–43. 4. Dess RT, Jackson WC, Suy S, Soni PD, Lee JY, Abugharib AE, et al. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Cancer 2017;123:1635–42. 5. King CR, Collins S, Fuller D, Wang P-C, Kupelian P, Steinberg M, et al. Health-related quality of life after stereotactic body radiation therapy for localised prostate cancer: results from a multi-institutional consortium of prospective trials. Int J Radiat Oncol Biol Phys 2013;87:939–45. 6. Bhattasali O, Chen LN, Woo J, Park J-W, Kim JS, Moures R, et al. Patient-reported outcomes following stereotactic body radiation therapy for clinically localised prostate cancer. Radiat Oncol 2014;9:52. 7. Boyer MJ, Papagikos MA, Kiteley R, Vujaskovic Z, Wu J, Lee WR. Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer. Radiat Oncol 2017;12:14. 8. Lagendijk JJW, Raaymakers BW, van Vulpen M. The Magnetic Resonance Imaging–Linac System. Semin Radiat Oncol 2014;24:207–9. 9. Winkel D, Bol GH, Kroon PS, van Asselen B, Hackett SS, Werensteijn-Honingh AM, et al. Adaptive radiotherapy: The Elekta Unity MR-linac concept. Clin Transl Radiat Oncol 2019;18:54–9. 10. de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHMW, den Hartogh MD, van der Voort van Zyp JRN, et al. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions. Radiother Oncol 2020;151:88– 94. 11. de Muinck Keizer DM, Willigenburg T, der Voort van Zyp JRN van, Raaymakers BW, Lagendijk JJW, Boer JCJ de. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac. Radiother Oncol 2021;162:162–9. 12. Schaule J, Chamberlain M, Wilke L, Baumgartl M, Krayenbühl J, Zamburlini M, et al. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer. Radiat Oncol 2021;16:189. 13. Kontaxis C, de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, den Hartogh MD, van der Voort van Zyp JRN, et al. Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5 T magnetic resonance imaging and linear accelerator system. Phys Imaging Radiat Oncol 2020;15. 14. Menten MJ, Mohajer JK, Nilawar R, Bertholet J, Dunlop A, Pathmanathan AU, et al. Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging. Radiother Oncol J 2020;145:88–94. 15. Hijab A, Tocco B, Hanson I, Meijer H, Nyborg CJ, Bertelsen AS, et al. MR-Guided Adaptive Radiotherapy for Bladder Cancer. Front Oncol 2021;11. 16. Bohoudi O, Bruynzeel AME, Tetar S, Slotman BJ, Palacios MA, Lagerwaard FJ. Dose accumulation for personalised stereotactic MR-guided adaptive radiation therapy in prostate cancer. Radiother Oncol 2021;157:197–202. 17. Wang K, Mavroidis P, Royce TJ, Falchook AD, Collins SP, Sapareto S, et al. Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response. Int J Radiat Oncol Biol Phys 2021;110:237– 48. 18. Willigenburg T, de Muinck Keizer DM, Peters M, Claes A, Lagendijk JJW, de Boer HCJ, et al. Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator. Clin Transl Radiat Oncol 2021;27:50–6. 19. de Muinck Keizer DM, van der Voort van Zyp JRN, de Groot-van Breugel EN, Raaymakers BW, Lagendijk JJW, de Boer HCJ. On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy. Phys Imaging Radiat Oncol 2021;19:90–5. 20. Denis de Senneville B, Zachiu C, Ries M, Moonen C. EVolution: an edge-based variational method for non-rigid multi-modal image registration. Phys Med Biol 2016;61:7377–96.
RkJQdWJsaXNoZXIy MTk4NDMw